Barr Announces Favorable Ruling in Mirapex(R) Patent... (he Hatch-Waxman Act. In March 2008 thepa...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> BIOLOGY >> TECHNOLOGY

Barr Announces Favorable Ruling in Mirapex(R) Patent Challenge

Date:6/26/2008

he Hatch-Waxman Act. In March 2008, the patent infringement case was heard in front of Judge Farnan.

Mirapex (pramipexole dihydrochloride) had annualized sales of approximately $381 million for the twelve months ended April 2008, based on IMS sales data.

About Barr Pharmaceuticals, Inc.

Barr Pharmaceuticals, Inc. is a global specialty pharmaceutical company that operates in more than 30 countries worldwide and is engaged in the development, manufacture and marketing of generic and proprietary pharmaceuticals, biopharmaceuticals and active pharmaceutical ingredients. A holding company, Barr operates through its principal subsidiaries: Barr Laboratories, Inc., Duramed Pharmaceuticals, Inc. and PLIVA d.d. and its subsidiaries. The Barr Group of companies markets more than 120 generic and 27 proprietary products in the U.S. and approximately 1,025 products globally outside of the U.S. For more information, visit http://www.barrlabs.com.

Forward-Looking Statements

Except for the historical information contained herein, the statements made in this press release constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements can be identified by their use of words such as "expects," "plans," "projects," "will," "may," "anticipates," "believes," "should," "intends," "estimates" and other words of similar meaning. Because such statements inherently involve risks and uncertainties that cannot be predicted or quantified, actual results may differ materially from those expressed or implied by such forward-looking statements depending upon a number of factors affecting the Company's business. These factors include, among others: the difficulty in predicting the timing and outcome of legal proceedings, including patent-related matters such as patent challenge settlements and
'/>"/>

SOURCE Barr Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

4

GOOD

Page: 1 2 3 4
Related biology technology :

1. Impact Systems Announces Completion of Successful Enterprise Content Migrations to Documentum 6
2. ValGenesis, Inc. Announces Worldwide Release of Validation Life Cycle Management System - ValGenesis 2.0
3. Wyeth Pharmaceuticals Announces Organizational Change
4. Spectral announces continuing support for the combination of EAA(TM) and anti-endotoxin therapeutics
5. Pinnacle Biologics Announces Stock Purchase Agreement With MedImmune
6. Cell Biosciences Announces New Leadership
7. Rosetta Genomics Announces Plans to Recruit a New Chief Financial Officer
8. BioNeutral Laboratories Announces the Appointment of Stephen Browand as a Director to Head Military, Homeland Security and Governmental Affairs
9. Lixte Biotechnology Holdings Announces Extension of Its Cooperative Research and Development Agreement With The National Institute of Neurological Disorders and Stroke, National Institutes of Health, for Development of Anti-Brain Cancer Drugs
10. SciQuest Announces Newest Life Sciences Customer; BioMarin Pharmaceutical Drives Spending Effectiveness with Automated, Intuitive Procurement
11. Quest PharmaTech Announces Interim Results from Phase I/II Clinical Trial for Photodynamic Treatment for Hair Removal

Post Your Comments:

(Date:6/19/2013)... BioConvergence team members Curtis Strother and ... BioLogistics Summit in San Francisco earlier this month. ... IQ and IQPC, addressed the increasingly complex logistical ... attributed to current trends of globalization, outsourcing, and ... is an increase in movement, which is often ...

(Date:6/19/2013)... 19, 2013 Express Diagnostics Int’l, Inc., ... announced that it has received Class III medical device ... its DrugCheck® NxStep Onsite Drug Screen Cup ... rapid screening device in near-patient settings, such as physicians’ ... received Health Canada Class III approval for 24 different ...

(Date:6/18/2013)... China Cord Blood Corporation (NYSE: CO ) ... blood collection, laboratory testing, hematopoietic stem cell processing, and ... financial results for the fourth quarter and full year ... Fourth Quarter of Fiscal 2013 Highlights ... increased by 33.3% to RMB133.0 million ($21.4 million) from ...

(Date:6/18/2013)... June 18, 2013 Demanding industrial and ... engineered of synthetic Sapphire and Glass Ball Lenses, now ... Swiss Jewel Company , of Philadelphia , PA. ... and collimating the light beams without the need for ... and natural durability (9 mohs) make it the ideal ...

[0] BioConvergence® Presents at BioLogistics Summit on Risk Matrix for Biosamples during Shipment [0] Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval [0] China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 [0] Swiss Jewel Introduces the Crown Jewels of Fiber-Optic Connectors

... You say you want a revolution... Well, you know... We ... it's evolution... Well, you know... We all want to change ... know that you can count me out? , , ... is the 25th anniversary of John Lennons death, but his ...

... sure hit a nerve. , , I heard from a ... Web 2.0 is spelled b-u-b-b-l-e, and who want none of it. ... could use a healthy dose of caution to prevent the heavy ... the group. , ,Indeed, in dozens of conversations with start-ups seeking ...

... Governor Jim Doyle said the state Department of Agriculture ... the 2005 budget to boost the development of renewable ... $700,000 will go into grants of up to $150,000 ... fuels, waste reclamation systems or materials. Proposals are due ...

Cached Biology Technology:Are you ready for the next workplace revolution? 2 Are you ready for the next workplace revolution? 3 Are you ready for the next workplace revolution? 4 Can we prevent Web 2.0 from being a bubble? 2 Can we prevent Web 2.0 from being a bubble? 3

Are you ready for the next workplace revolution?Can we prevent Web 2.0 from being a bubble?Doyle offers $700,000 in grants to bio-energy projects

(Date:6/19/2013)... the patients who received injections of steroids contaminated ... England Compounding Center has found that some patients ... experience a worsening of their symptoms and that ... especially among those individuals who received injections from ... with an editorial by UC Davis Assistant Professor ...

(Date:6/19/2013)... DC The Microbial Diversity Course at the Marine ... named a Milestones in Microbiology site by the ... Milestones in Microbiology program recognizes institutions and the ... contributions toward advancing the science of microbiology. ... the site is scheduled for Saturday, June 22, ...

(Date:6/19/2013)... -- MedNet Solutions , a global life sciences ... pleased to announce its participation in the 2013 DIA ... Boston . This represents the 10 th ... eClinical solutions, has exhibited at this premier industry event. ... EDC , MedNet,s latest, easy-to-use eClinical technology platform. ...

Breaking Biology News(10 mins):Evolution of an outbreak: Complications from contaminated steroid injections 2 Microbial diversity course designated as a 'Milestones in Microbiology' site 2 MedNet Solutions To Spotlight iMedNet EDC At The 49th DIA Annual Meeting 2

[0] Evolution of an outbreak: Complications from contaminated steroid injections [0] Microbial diversity course designated as a 'Milestones in Microbiology' site [0] MedNet Solutions To Spotlight iMedNet EDC At The 49th DIA Annual Meeting

... sequencing of the zebra finch genome, a new resource ... A thematic series published by BioMed Central, the open ... As part of the series, a study published ... genes related to steroid receptors and estrogen biosynthesis. Researchers ...

... you find yourself leading groups, or are you naturally more ... want to be a leader you,re better off at the ... the action. In a series of experiments on crowd ... at the University of Leeds also found that successful leaders ...

... the adult brain is well known. It is what is ... ventricles. This is where neural or brain stem cells reside, ... many years now, the subventricular zone has been suspected to ... the most deadly type of which is glioblastoma. ...

Cached Biology News:Follow the leader: How those in charge make themselves known 2 Brain tumors: Tissue stem cell turning into tumor stem cell 2

Further facts from the songbird genome Follow the leader: How those in charge make themselves known Brain tumors: Tissue stem cell turning into tumor stem cell

SDS-OutT Precipitation Reagent...

Extracti-Gel D Detergent Removing Gel...

... FLA-5000 imaging system allows scanning ... as large as 40 x ... as 25 microns. This system ... electrophoresis in the proteomics field ...

... Biometras T1 Thermocycler provides high speed ... been optimized with a TGradient Thermocycler can ... thermocycler comes with a silver block for ... for 384 well plates or in-situ applications ...

Biology Products:

SDS-OUT PRECIP. Kit from Pierce Biotechnology, Inc.EXTRACTI-GEL D from Pierce Biotechnology, Inc.FLA-5000 Imaging System from FUJIFILM Life Science T1 Thermocylcer 384 from LABREPCO, Inc.